Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Credo Science LLC is currently managing 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. This level of activity suggests a focused effort to protect its scientific innovations. The company is actively engaged in the prosecution process to resolve these outstanding matters.
The portfolio is being reviewed by 2 distinct examiners across 2 distinct art units. This indicates that the company's technology is being assessed by different specialized departments within the patent office. Having 2 distinct examiners means that the company must tailor its responses to two different individuals, each of whom may have a unique interpretation of the 2 pending office actions.
RAO, PADMAJA S is the busiest examiner for this portfolio. This examiner is responsible for 1 busiest examiner pending office action. Since there are 2 pending office actions in total, RAO, PADMAJA S handles a portion of the current workload. The company's progress in the Biotechnology & Pharmaceuticals area will depend on its ability to successfully navigate the requirements of both RAO, PADMAJA S and the other examiner.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RAO, PADMAJA S | 1 | 70.7% | +36.8% |
| SASAN, ARADHANA | 1 | 64.5% | +26.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18000918 | HEMP SPROUT PRODUCTS AND METHODS FOR PRODUCING SAME | SASAN, ARADHANA | 126d overdue |
| 18263205 | LIMONENE EFFECTS ON TETRAHYDROCANNABINOL (THC)-INDUCED ANXIETY | RAO, PADMAJA S | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18000918 | HEMP SPROUT PRODUCTS AND METHODS FOR PRODUCING SAME | SASAN, ARADHANA | 126d overdue |
| 18263205 | LIMONENE EFFECTS ON TETRAHYDROCANNABINOL (THC)-INDUCED ANXIETY | RAO, PADMAJA S | — |
| Art Unit | Apps |
|---|---|
| 1627 | 1 |
| 1615 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18263205 | LIMONENE EFFECTS ON TETRAHYDROCANNABINOL (THC)-INDUCED ANXIETY | RAO, PADMAJA S | 1627 | §101§102§103DP | Non-Final OA | — | Pending | Jul 27, 2023 |
| 18000918 | HEMP SPROUT PRODUCTS AND METHODS FOR PRODUCING SAME | SASAN, ARADHANA | 1615 | §103§112 | Final Rejection | 126d overdue | Pending | Dec 06, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial